204 related articles for article (PubMed ID: 33915640)
1. [Clinical and pathological analysis of ocular adnexal diffuse large B-cell lymphoma].
Li J; Wang YC; Chen LX; Lin JY
Zhonghua Yan Ke Za Zhi; 2021 May; 57(5):366-371. PubMed ID: 33915640
[No Abstract] [Full Text] [Related]
2. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
Rasmussen PK
Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
[TBL] [Abstract][Full Text] [Related]
3. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
[TBL] [Abstract][Full Text] [Related]
4. [Clinical pathological characteristics analysis of ocular adnexal follicular lymphoma].
Li J; Wang YC; Lin JY
Zhonghua Yan Ke Za Zhi; 2023 Nov; 59(11):930-936. PubMed ID: 37936361
[No Abstract] [Full Text] [Related]
5. Association of Disease Location and Treatment With Survival in Diffuse Large B-Cell Lymphoma of the Eye and Ocular Adnexal Region.
Ahmed AH; Foster CS; Shields CL
JAMA Ophthalmol; 2017 Oct; 135(10):1062-1068. PubMed ID: 28880986
[TBL] [Abstract][Full Text] [Related]
6. [Prognosis analysis of primary breast diffuse large B cell lymphoma].
Zhu YH; Meng WJ; He LH; Jia YS; Tong ZS
Zhonghua Zhong Liu Za Zhi; 2019 Mar; 41(3):235-240. PubMed ID: 30917462
[No Abstract] [Full Text] [Related]
7. [Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance].
Qu Y; Lu XZ; Wang RX; Hei XF; Li J; Xiao BT; Jia ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Apr; 32(2):450-457. PubMed ID: 38660851
[TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
[TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of
Ting CY; Chang KM; Kuan JW; Sathar J; Chew LP; Wong OJ; Yusuf Y; Wong L; Samsudin AT; Pana MNBM; Lee SK; Gopal NSR; Puri R; Ong TC; Bahari SK; Goh AS; Teoh CS
Int J Med Sci; 2019; 16(4):556-566. PubMed ID: 31171907
[No Abstract] [Full Text] [Related]
10. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
[TBL] [Abstract][Full Text] [Related]
11. Diffuse large B-cell lymphoma of the ocular adnexal region: a nation-based study.
Rasmussen PK; Ralfkiaer E; Prause JU; Sjö LD; Toft PB; Siersma VD; Heegaard S
Acta Ophthalmol; 2013 Mar; 91(2):163-9. PubMed ID: 22551232
[TBL] [Abstract][Full Text] [Related]
12. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
[No Abstract] [Full Text] [Related]
13. MicroRNA profiling in ocular adnexal lymphoma: a role for MYC and NFKB1 mediated dysregulation of microRNA expression in aggressive disease.
Hother C; Rasmussen PK; Joshi T; Reker D; Ralfkiær U; Workman CT; Heegaard S; Ralfkiær E; Grønbæk K
Invest Ophthalmol Vis Sci; 2013 Aug; 54(8):5169-75. PubMed ID: 23821202
[TBL] [Abstract][Full Text] [Related]
14. [Ki-67 proliferative index in non-Hodgkin's lymphoma and its clinical significance].
Li J; Hu R; Liao AJ; Shi HY; Yan W; Liu ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):935-9. PubMed ID: 21867618
[TBL] [Abstract][Full Text] [Related]
15. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
[TBL] [Abstract][Full Text] [Related]
16. Impact of initial chemotherapy cycles and clinical characteristics on outcomes for HIV-associated diffuse large B cell lymphoma patients: The Central and Western China AIDS Lymphoma League 001 study (CALL-001 study).
Wang C; Wu Y; Liu J; Min H; Huang Y; Wei G; Zhang W; Wang M; Tang X; Zhou H; Chen Y; Liu Y
Front Immunol; 2023; 14():1153790. PubMed ID: 37063928
[TBL] [Abstract][Full Text] [Related]
17. Ocular adnexal follicular lymphoma: a multicenter international study.
Rasmussen PK; Coupland SE; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; McKelvie P; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Heegaard S
JAMA Ophthalmol; 2014 Jul; 132(7):851-8. PubMed ID: 24763920
[TBL] [Abstract][Full Text] [Related]
18. Ocular adnexal lymphoma staging and treatment: American Joint Committee on Cancer versus Ann Arbor.
Graue GF; Finger PT; Maher E; Della Rocca D; Della Rocca R; Lelli GJ; Milman T
Eur J Ophthalmol; 2013; 23(3):344-55. PubMed ID: 23397158
[TBL] [Abstract][Full Text] [Related]
19. [Nodal T-follicular helper cell lymphoma, angioimmunoblastic-type associated with diffuse large B-cell lymphoma: a clinicopathological study].
Wang GN; Zhao WG; Zhang DD; Zhang YP; Liu EJ; Lu SS; Li WC
Zhonghua Bing Li Xue Za Zhi; 2023 Sep; 52(9):918-923. PubMed ID: 37670621
[No Abstract] [Full Text] [Related]
20. [Clinical characteristics of 46 pediatric diffuse large B-cell lymphoma and treatment outcome].
Huang S; Yang J; Jin L; Duan YL; Zhang M; Zhang NN; Li Q; Zhang N; Zhou CJ; Zhang YH
Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):774-779. PubMed ID: 31594064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
